Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2068

Lexicon ends commercial work to focus on R&D

$
0
0
Lexicon Pharmaceuticals is reverting to a clinical development company after facing repeated setbacks at the FDA for its type 1 diabetes and chronic kidney disease drug. The Texas biotech is slashing its commercial force and ...

Viewing all articles
Browse latest Browse all 2068

Trending Articles